Type 2 diabetes affects about 25 million people in the United States, or more than 8% of the nation’s population. Type 2 diabetics suffer from an excess of blood sugar (glucose) because their bodies do not use insulin properly.
Diabetics who were hospitalized for heart failure after taking Onglyza are asking whether they should receive compensation. Personal injury lawyers who represent clients in cases against pharmaceutical companies are basing lawsuits on the failure of drug manufacturers to warn diabetics that taking Onglyza could increase their risk of heart failure if they were already suffering from or prone to heart disease.
Peripheral neuropathy is a health condition associated with damage to the nerves that connect the brain and spinal column to the rest of the body. Individuals who suffer from peripheral neuropathy usually experience symptoms in their hands or feet, including tingling, numbness, and sharp or burning pain. However, peripheral neuropathy can attack any part of the body, including glands, organs, and the digestive tract. In extreme cases, the condition may cause permanent injuries, including muscle weakness that leads to paralysis.
Zimmer, the Indiana-based manufacturer of artificial joints, has recalled a key component of its Persona knee replacement system. Patients and their doctors have complained that the implant component comes loose, creating instability in the knee, ongoing pain, and the potential for further complications when patients have surgery to replace the knee implant.